Tyra Biosciences to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., March 29, 2023 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced…

Click here to view original post